separately and in combination to neonatal milmi mice for by osteoclasts would be expected to reduce their function. Defec-7 consecutive d. Bone turnover, osteoclast numbers, super-tive superoxide production by the white cells of patients with oxide generation by white cells, and hematocrit were as-chronic granulomatous disease has been restored using rIFN sessed. rIFN, M-CSF, and a combination of the cytokines therapy (7) . In addition, the production of oxygen-derived free stimulates oxygen-derived free radical production by white radicals has been located within the ~m e d border areas of active cells and increased bone resorption. rIFN resulted in a ~~f e~c l a s t s (3) . These findings suggest that rIFN might help to reduction in the number of osteoclasts. This reduction in reverse the osteopetrotic defect through the stimulation of supernumber was ameliorated by M-CSF. M-CSF alone and in oxide production. combination with rIFN resulted in improved hematopoietic
The OP/OP mouse has a defect in the production of mature function, increased weight gain, and increased physical functional macrophages and osteoclasts (8) bone resorption have been seen after treatment with M-CSF (9, 10) . It has been demonstrated that M-CSF in the in vitro hematopoietic colonies of op/op mice is necessary for the restoration Abbreviations of osteoclast formation (1 I). In contrast to the animal model. a rIFN, recombinant interferon-y defect in M-CSF production and function is not expected in the M-CSF, macrophage-colony stimulating factor majority of patients with congenital malignant osteopetrosis, milmi, microphthalmic mutant C57B1/6 mouse because in general there has not been a reduced number of +/mi, heterozygote microphthalmic C57B1/6 mouse macrophages or osteoclasts. Indeed. Orchard ef al. (12) have +/+, normal C57B1/6 mouse demonstrated normal circulating levels of biologically active M-NBT, nitroblue tetrazolium CSF in patients with severe congenital osteopetrosis. The possibility that there could be an M-CSF receptor defect that could be treated with high doses of M-CSF has not been explored. Thus, there is the possibility that pharmacologic doses could result in improved bone resorption in nondeficient animals.
Severe. congenital osteopetrosis is a fatal disorder that is char-gei:il ~~~~~$ ; ; : t : ; : : ,?A ~~$ h~~~~, " " $ acterized by the inability of the osteoclast to resorb bone. Due to inadequate bone remodeling, medullary cavities are severely of macrophages and osteoclasts (7) . The osteoclasts and the white cells have defective superoxide production (1 The cortical bone surrounding a relatively small marrow cavity (.\I) is highly porous. except for a dense outer compact bone rim and a thin inner compact bone rim (arrow,) surrounding the marrow cavity. C. rIFN-treated mutant. Note the increase in the size of the marrow cavity (,W) surrounded by the inner compact bone rim (arrow,) and the increased cellularity within the enlarged marrow space. The cortical bone surrounding the marrow cavity shows increased porosity. D. M-CSF-treated mutant. Note similar changes in tibial morphology of this specimen as described for panel C. E. Combination rlFY and M-CSF treatment. In this specimen. most of the inner compact bone rim (arrow.) surrounding the enlarged marrow cavity (.W) has been eroded. and is now continuous with a porous cortical bone that structurally resembles trabecular bone. 9 p < 0.00 1 (compared with milmi saline).
11 No significant differences were found between saline-and rlFN-treatt ll p < 0.008 (compared with colonies without rlFN).
:d normal animals. Hematologic measurements. After 7 consecutive d of treatment, the mice were weighed and killed with a lethal intraperitoneal injection of sodium pentobarbital (100 mg/kg). Blood was drawn (50 pL) by cardiac puncture and used to determine the hematocrit. The spleen of each animal was dissected free and placed into separate, sterile, 32-mm plastic Petri dishes containing PBS, pH 7.3. The spleens were minced, and the tissue debris was separated by filtering over sterile gauze into 13-mL plastic centrifuge tubes. The cellular suspension was centrifuged at 1200 x g for 15 min at room temperature. The supernatant was discarded. and the pellet was resuspended in 2.2 mL of sterile agar-based BGJb media (Sigma, St. Louis, MO) with 10.0% FCS (Sigma), 1 % penicillin-streptomycin solution (Sigma), and supplemented with 10 ng/mL of CSF-1 (Genzyme, Cambridge, MA). One m i of the suspension was piated into each of rwo i 6-mm wells (24-well plates. Corning, Corning. NY). Only one of these wells contained 40 pg rIFN: the other well served as a control. The cells were incubated at 37"C, in 5.0% COz and air for 7 d.
After incubation. 550 pL of a filtered NBT solution [5.0 mg NBT (Sigma), 60 ILL DMSO (Sigma), 1.6 mL FCS. 2.9 mL BJGh (Sigma), pH 7.31 was added to each well and incubated for 30 min at 37°C. NBT staining intensity of 20 hematopoietic colonies per well was assessed (OD units) using a densitometry analysis system (Cue 2. Opelco, Washington DC).
His~omorphomc~r!,. The tibias of each animal were dissected free of soft tissue. sectioned in half at the mid-diaphysis. and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer. The specimens were decalcified in 5% EDTA, dehydrated in increasing concentrations of ethanol, and embedded in Spurr's resin (Polysciences, Wanington, PA). Serial cross-sections (1 to 2 pm) of the mid-diaphysis were stained with toluidine blue (1% aqueous solution) and analyzed histomorphometrically using an Olympus inverted microscope and a digital analysis (Cue 3, Opelco). The percentage of the bone marrow space relative to the total bone area was measured. Marrow cellularity was measured by determining the number of nuclei within a given marrow space area (100 pm'). Total osteoclast number was assessed within a standardized area of 1600 pm2 of marrow space at 2500x.
Statistical anal~vsis. All data have been expressed as mean k SEM. Differences between experimental and control groups were analyzed for significance using the t test. Relationships between variables were measured using the Pearson product-moment correlation coefficient (r,).
RESULTS
The milmi mice treated with either rIFN. M-CSF. or a combination of the two cytokines demonstrated a significant increase in the percentage of the bone cross-sectional area containing marrow elements (Fig. 1 ) compared with that of sham-treated mi/mi mice (Table I . p < 0.00 1 ).
Microphthalmic mice were noted to have 48% more osteoclasts than their normal littermates ( p < 0.000 1). During therapy, the total osteoclast number was significantly decreased in mi/mi mice that received rIFN (Table 2, p < 0.03). Mutant animals that received M-CSF. either alone or in combination with rIFN. demonstrated no significant change in total osteoclast number when compared with saline-treated mutants but did show a significant increase compared with rIFN-treated mutant animals (Tabit: 2. p < 0.004).
The bone sections (Fig. 2) original magnification x 1000. p < 0.00 1 ). There is a positive correlation between the marrow cellularity and the size of the bone marrow space ( r = 0.89. p < 0.04).
The mean hematocrits of the mutant animals treated with saline and with rlFN were significantly lower than those of the normal animals (Table 3 . p < 0.05). Conversely. the mean hematocrits of animals treated with M-CSF alone or in combination with rIFN were not different from control (Table 3) .
The OD of the NBT-stained hematopoietic colonies was greater in colonies from mi/mi mice treated with rlFN. M-CSF. or a combination of the cq-tokines than in colonies from mutants given saline (Table I . p < 0.00 1 ). Cultured hematopoietic colonies from the spleens of milmi responded to r I F 3 with a significant increase in NBT staining. regardless of the cq~okine treatment h riro (Table 1 . p < 0.02). The colonies grown from spleen cells of normal mice showed no significant increase in NBT staining due to 111 1.11.0 r l N treatment: however. colonies did demonstrate an increase when treated in rirro ( 4 p < 0.0008 (compared with milmi saline).
11 p < 0.001 (compared with milmi saline). 1 1 p < 0.004 (compared with milmi saline).
demonstrated a wide variability (data not shown). Therefore, a significant increase or decrease in weight gain after cytokine treatment when compared with the control mutants could not be ascertained. However. the mi/mi mice treated with rIFN alone decreased their weight by 0.42 5 0.375 g (+SEM, n = 16).
The mutants receiving rIFN in combination with M-CSF increased their weight by 1.38 + 0.375 g (+SEM, n = 16). This weight increase represented a significant difference when compared with the rIFN-treated group that lost weigth ( p < 0.002).
DISCUSSION
The hallmark of osteopetrosis is defective bone resorption resulting from an inadequacy of osteoclastic number or function. Reversal of the osteopetrotic condition depends upon improving bone resorption. After 7 d of treatment, all cytokine-treated animals demonstrated a significant increase in the amount of bone marrow space. This suggested that net bone resorption (the amount of bone resorption relative to formation) had improved. The improvement in bone resorption dynamics occurred in all treatment groups. In normal animals, there was no change in the percentage of the bone cross-section occupied by bone marrow during rIFN administration. This is not surprising, because the marrow space extends to the outer, single rim of dense cortical bone.
The administration of rIFN to either osteopetrotic mice or their normal littermates did result in a decrease in total osteoclast number. However, it was also demonstrated that in rIFN-treated animals the overall level of bone resorption, as indicated by an increase in marrow space, improved. M-CSF in combination with rIFN restored the total osteoclast number to the level seen in sham-treated animals. The combination therapy was superior to all other therapies, improving the osteopetrotic condition.
Ideally, an increase in marrow space and bone turnover should translate into an improvement of hematopoietic function. The hematocrits measured in the M-CSF-treated animals were not significantly different from those in normal control animals. In addition, there was a significant increase in marrow cellularity in the animals treated with rIFN, M-CSF, or a combination of both cytokines in comparison to controls. As the marrow spaces increased, the number of bone marrow elements within them increased in parallel, suggesting that hematopoiesis was increased along with the intramedullary volume. Longer treatment may result in more demonstrable changes in the peripheral blood.
The hematopoietic colonies grown from the dispersed spleen cells demonstrated a significant increase in NBT reduction in all cytokine-treatment groups. The greatest increase was seen in colonies grown from mutants treated with a combination of rIFN and M-CSF. However, the increased NBT reduction by spleen ceii coionies cuitured I'rotn the mutants treated with M-CSF alone would suggest that not only rIFN but also M-CSF enhances superoxide production. Normal mice receiving rIFN in vivo had no significant increase in NBT reduction. However, the white cells from the hematopoietic colonies of both the normal and mi/mi mice demonstrated a significant increase when cultured with rIFN in vitro.
Death in patients with osteopetrosis frequently occurs secondary to infection. long before neutropenia is present (2) . Thus. the increase in superoxide generation seen in the white cells of all M-CSF and rIFN treatment groups may prove important. The marked increase in the oxygen radical formation of white cell colonies demonstrated in the present study may provide preclinical data. paving the way for trials of rIFN and M-CSF among osteopetrotic patients. in attempts to reduce death due to infection.
Weight gain was used to assess the overall health ofthe animals. When compared with the saline-treated controls, only the groups of animals receiving either M-CSF or a combination of cytokines demonstrated a significant increase in net weight gain. Mutant animals treated with rIFN lost weight, although they demonstrated biochemical and histologic improvement. We have not assessed the reason for this phenomenon, but suspect that it results from the anorexia (secondary to flu-like symptoms) analogous to that occasionally observed in humans treated with rlFN (1 5).
Our studies provide evidence that M-CSF and rIFN, whether administered independently or in combination, are capable of increasing bone resorption relative to bone formation in an osteopetrotic mutant. The mi/mi mutant does not have reduced numbers of osteoclasts or evidence of an M-CSF deficiency. M-CSF was demonstrated to increase the therapeutic effects of rIFN administration. The increase in cellularity of the marrow spaces also suggests that the cytokines, whether administered independently or in combination, improve the hematopoiesis of the osteopetrotic animals, reducing the severity of the leukoerythroblastic anemia.
Interferon-y has been shown to reduce the number of osteoclasts ( 16) and the level of calvarial bone resorption ( 17) in tissues harvested from normal animals. However, in the present study, it appears that osteoclastic bone resorption was improved. Improved osteoclastic activity alone cannot be proven to have caused all of the change in bone marrow space noted. Because we did not specifically measure bone formation, it is possible that osteoblastic activity was inhibited. Nonetheless, the primary defect in the microphthalmic mouse is in osteoclastic function. Thus, an improved balance between bone formation and resorption implies an increase in osteoclastic function.
Superoxide generation appears to be an important element in achieving a normal level of osteoclastic function (3, 18) . Microphthalmic mice that received both M-CSF and rIFN demonstrated the most significant improvement in cellular composition of the marrow space and augmentation of superoxide production, compared with sham animals. Hence, the combination of the two cytokines may result in an even more rapid improvement in the osteopetrotic condition than either cytokine administered separately. Although they did not elucidate the precise biochemical defect in osteopetrosis, the present studies suggest that rlFN and/or M-CSF administered to mi/mi mice stimulates bone resoprtion, hematopoiesis, and immune competence, and thereby ameliorates the osteopetrotic condition.
